Skip to main content
. 2025 Sep 25;20:834. doi: 10.1186/s13018-025-06269-y

Table 3.

HRs of muscle, adipose and bone parameters per SD decrease for ITF death risk

Unadjusted Adjusteda Adjustedb Adjustedc
HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
G.MaxM area (cm2) 0.91(0.86,0.97) < 0.01 0.96(0.90,1.03) 0.28 0.96(0.90,1.03) 0.29 0.96(0.89,1.03) 0.22
G.MaxM density (HU) 0.97(0.93,1.01) 0.09 1.00(0.96,1.05) 0.98 1.00(0.96,1.05) 0.95 1.00(0.96,1.05) 1.00
G.Med/MinM area (cm2) 0.93(0.88,0.99) 0.03 0.99(0.93,1.06) 0.77 0.99(0.93,1.06) 0.77 0.99(0.93,1.06) 0.76
G.Med/MinM density (HU) 0.97(0.93,1.01) 0.15 1.03(0.97,1.09) 0.36 1.03(0.97,1.09) 0.36 1.02(0.97,1.08) 0.41
MM area (cm2) 0.96(0.94,0.99) < 0.01 0.99(0.96,1.01) 0.31 0.99(0.96,1.01) 0.31 0.98(0.96,1.01) 0.25
MM density (HU) 0.96(0.91,1.01) 0.11 1.01(0.95,1.08) 0.69 1.02(0.95,1.08) 0.63 1.01(0.95,1.08) 0.68
MSAT area (cm2) 0.98(0.96,0.99) < 0.01 0.98(0.96,1.00) 0.01 0.98(0.96,1.00) 0.01 0.98(0.96,1.00) 0.01
MSAT density (HU) 1.06(1.02,1.11) < 0.01 1.05(1.01,1.09) 0.02 1.05(1.01,1.09) 0.02 1.05(1.01,1.09) 0.02
TH aBMD (mg/cm2) 0.99(0.99,1.00) < 0.01 1.00(0.99,1000) 0.04 1.00(0.99,1.00) 0.04 1.00(0.99,1.00) 0.03
FN aBMD (mg/cm2) 0.99(0.99,1.00) < 0.01 1.00(0.99,1.00) 0.42 1.00(0.99,1.00) 0.37 1.00(0.99,1.00) 0.30
TR aBMD (mg/cm2) 0.99(0.99,1.00) < 0.01 1.00(0.99,1.000) 0.05 1.00(0.99,1.00) 0.04 1.00(0.99,1.00) 0.03
IT aBMD (mg/cm2) 1.00(0.99,1.00) < 0.01 1.00(0.99,1.000) 0.06 1.00(0.99,1.00) 0.05 1.00(0.99,1.00) 0.04
Parker Mobility Score 1 0.96(0.83,1.11) 0.59 NA NA NA NA NA NA
Parker Mobility Score 2 0.81(0.72,0.90) < 0.01 NA NA NA NA NA NA
ASA score 1.94(0.99,3.78) 0.05 NA NA NA NA NA NA
CCI 2.59(1.22,5.47) 0.01 NA NA NA NA NA NA

* ITF, intertrochanteric fracture; aBMD, areal bone mineral density; ASA, American Society of Anesthesiologists; CCI, Charlson Comorbidity Index; HR, hazard ratio; SD, standard deviance; CI, confidence interval; G.MaxM, gluteus maximus muscle; G.Med/MinM, gluteus medius and minimus muscle; MM, midthigh muscle; MSAT, mid-thigh subcutaneous adipose tissue; TH, total hip; FN, femoral neck; TR, trochanter; IT, intertrochanter

Note: Parker Mobility Score 1: assessment obtained prior to hip fracture surgery; Parker Mobility Score 2: assessment within 3 months prior to death; Group without death: assessment of mobility prior to follow-up visit

aAdjusted for age, BMI, and ASA score

bAdjusted for age, BMI, and CCI

cAdjusted for age, BMI, and Parker Mobility Score prior to hip fracture surgery